Clinical Laboratories: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, First Session, May 2, 1991, Volume 4
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
U.S. Government Printing Office, 1992 - Diagnosis, Laboratory
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
accrediting organizations agencies ALLEN-JONES Amendments of 1988 analytes areas Association believe BLILEY blood glucose blood glucose monitoring Budgeting Chairman cholesterol CLIA 88 Clinical Laboratory Improvement COLA Commission on Office committee complexity model concerns cost cytology cytopathology DEBOY developed diabetes DINGELL evaluate Federal final rule Financing Administration HCFA HCFA's Health Care Financing hematology impact inspection instruments issue Kroger laboratory director Laboratory Improvement Amendments laboratory performance laboratory services laboratory testing Level MACRAE Maryland Medicaid medical technologists Medicare ment Office Laboratory Assessment Oversight and Investigations Pap smear participants Pathologists patient percent personnel physician office laboratories physician office labs problems proficiency testing program proposed regulations proposed rule quality assurance quality control reagent strips regulatory requirements risk ROPER Scalettar sickle cell trait slides SMBC standards Subcommittee on Oversight subspecialty technical test results testimony Thank tion waivered tests WILENSKY WYDEN